
Fulgent Genetics FLGT
€ 12.35
-3.93%
Quartalsbericht 2025-Q3
hinzugefügt 07.11.2025
Fulgent Genetics EV/EBITDA 2011-2026 | FLGT
EV/EBITDA Jährlich Fulgent Genetics
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.58 | 8.07 | 143 | -21.5 | -44.8 | 104 | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 143 | -44.8 | 31.9 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 15.85 | -2.49 % | $ 171 M | ||
|
Agilent Technologies
A
|
27.4 | $ 115.06 | -0.29 % | $ 35 B | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
-7.71 | $ 1.13 | -2.59 % | $ 6.15 M | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
-100 | $ 16.05 | -3.83 % | $ 855 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 23.13 | -1.28 % | $ 642 M | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
Interpace Biosciences
IDXG
|
-6.02 | $ 2.3 | - | $ 10.2 M | ||
|
Charles River Laboratories International
CRL
|
22 | $ 175.65 | 0.06 % | $ 8.71 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Danaher Corporation
DHR
|
20.1 | $ 189.61 | -1.7 % | $ 135 B | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 493.53 | -1.59 % | $ 14.2 B | ||
|
Illumina
ILMN
|
70.5 | $ 120.93 | -2.22 % | $ 19.2 B | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 4.35 | -2.03 % | $ 403 M | ||
|
NeoGenomics
NEO
|
-33.5 | $ 7.69 | -3.17 % | $ 985 M | ||
|
Guardant Health
GH
|
-28.8 | $ 78.6 | -9.83 % | $ 9.85 B | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-2.25 | $ 2.69 | -1.82 % | $ 87.3 K | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.13 | -0.9 % | $ 4.89 M | ||
|
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | ||
|
Koninklijke Philips N.V.
PHG
|
55.6 | $ 28.31 | 0.62 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 106.81 | 0.1 % | $ 8.81 B | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 260.93 | -4.51 % | $ 21.7 B | ||
|
Natera
NTRA
|
-19.5 | $ 193.03 | -4.91 % | $ 19 B | ||
|
Celcuity
CELC
|
-2.38 | $ 117.14 | -6.02 % | $ 5.48 B | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 80.59 | -1.03 % | $ 5.44 B | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 191.51 | -3.19 % | $ 21.3 B | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 9.42 | -6.13 % | $ 2.04 B | ||
|
ENDRA Life Sciences
NDRA
|
0.831 | $ 4.94 | -6.97 % | $ 3.89 M | ||
|
Organovo Holdings
ONVO
|
0.992 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
0.274 | - | -16.95 % | $ 1.54 M | ||
|
National Research Corporation
NRC
|
21 | $ 16.48 | -3.34 % | $ 369 M |